Abstract
It is still not clear whether intact lipid vesicles can cross the human skin. Some reports in the literature indicate that transfersomes® can cross the skin. Other reports suggest that intact liposomes cannot cross the skin. Of course, the composition of the various formulations has to be taken into consideration before making such assertions. The present review examines the use of vesicles- elastic liposomes and ethosomes- for transdermal drug delivery. Liposomes are micro- or nano-structures formed from a bilayer of lipid surrounding an aqueous core. Elastic liposomes differ from conventional liposomes because they contain edge activators (surfactants) which impart elasticity and deformability. Ethosomes are efficient in facilitating percutaneous drug penetration. They are structurally similar to conventional liposomes in the sense that they are prepared from phospholipids but different because they contain a high concentration of ethanol. Both elastic liposomes and ethosomes are increasingly being used for delivering low and high molecular weight drugs. In this review, several reports are presented showing the usefulness of these vesicles and mechanistic insight sought as to why they may be effective in certain cases.
Keywords: Elastic liposomes, ethosomes, transdermal, dermal, vesicles.
Current Pharmaceutical Design
Title:Current Status of Ethosomes and Elastic Liposomes in Dermal and Transdermal Drug Delivery
Volume: 22 Issue: 33
Author(s): Kevin Ita
Affiliation:
Keywords: Elastic liposomes, ethosomes, transdermal, dermal, vesicles.
Abstract: It is still not clear whether intact lipid vesicles can cross the human skin. Some reports in the literature indicate that transfersomes® can cross the skin. Other reports suggest that intact liposomes cannot cross the skin. Of course, the composition of the various formulations has to be taken into consideration before making such assertions. The present review examines the use of vesicles- elastic liposomes and ethosomes- for transdermal drug delivery. Liposomes are micro- or nano-structures formed from a bilayer of lipid surrounding an aqueous core. Elastic liposomes differ from conventional liposomes because they contain edge activators (surfactants) which impart elasticity and deformability. Ethosomes are efficient in facilitating percutaneous drug penetration. They are structurally similar to conventional liposomes in the sense that they are prepared from phospholipids but different because they contain a high concentration of ethanol. Both elastic liposomes and ethosomes are increasingly being used for delivering low and high molecular weight drugs. In this review, several reports are presented showing the usefulness of these vesicles and mechanistic insight sought as to why they may be effective in certain cases.
Export Options
About this article
Cite this article as:
Ita Kevin, Current Status of Ethosomes and Elastic Liposomes in Dermal and Transdermal Drug Delivery, Current Pharmaceutical Design 2016; 22 (33) . https://dx.doi.org/10.2174/1381612822666160511150228
DOI https://dx.doi.org/10.2174/1381612822666160511150228 |
Print ISSN 1381-6128 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4286 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Anti-CD20 Antibody in Primary Sjogren's Syndrome Managemen
Current Pharmaceutical Biotechnology Nonstandard Drugs and Feasible New Interventions for Autoimmune Hepatitis: Part II
Inflammation & Allergy - Drug Targets (Discontinued) Anti-TNF-α Antibody Therapies in Autoimmune Diseases
Current Topics in Medicinal Chemistry Astrocyte`s RAGE: More Than Just a Question of Mood
Central Nervous System Agents in Medicinal Chemistry Defining and Regulating Acute Inflammatory Lesion Formation during the Pathogenesis of Multiple Sclerosis and Experimental Autoimmune Encephalomyelitis
CNS & Neurological Disorders - Drug Targets Desensitization Protocol for Rituximab-Induced Serum Sickness
Current Drug Safety Neurocysticercosis: The Enigmatic Disease
Central Nervous System Agents in Medicinal Chemistry Renin Angiotensin System (RAS) and Immune System Profile in Specific Subgroups with COVID-19
Current Medicinal Chemistry Gauging Reactive Metabolites in Drug-Induced Toxicity
Current Medicinal Chemistry Metformin and Inflammation: Its Potential Beyond Glucose-lowering Effect
Endocrine, Metabolic & Immune Disorders - Drug Targets A Study of Tryptophan Metabolism via Serotonin in Ventricular Cerebrospinal Fluid in HIV-1 Infection Using a Neuroendoscopic Technique
Current HIV Research Thalidomide as an Immunotherapeutic Agent: The Effects on Neutrophil- Mediated Inflammation
Current Pharmaceutical Design Recent Aspects of Osmotic Pump Systems: Functionalization, Clinical use and Advanced Imaging Technology
Current Drug Metabolism Uveitis in Horses, Rats and Man: What Do We Learn from Our Pets?
Current Immunology Reviews (Discontinued) Blood Atherogenicity as a Target for Anti-atherosclerotic Therapy
Current Pharmaceutical Design Stem Cell Aging and Age-Related Cardiovascular Disease: Perspectives of Treatment by Ex-vivo Stem Cell Rejuvenation
Current Drug Targets Juvenile Systemic Lupus Erythematosus
Current Pediatric Reviews Role of Oxidized Phospholipids in Acute Lung Injury
Current Respiratory Medicine Reviews Histone Deacetylase Inhibitors: New Promise in the Treatment of Immune and Inflammatory Diseases
Current Drug Targets Neutrophil MiRNA-128-3p is Decreased During Active Phase of Granulomatosis with Polyangiitis
Current Genomics